The Turkish Journal of Ear Nose and Throat (Tr-ENT) is published periodical four times per year on March, June, September and December and related subjects in the field of original research, short clinical report, surgical techniques, case report, invited reviews and letters to the editor are published in English.
Articles which are not previously published in another journal or not currently under evaluation elsewhere can be accepted for the journal. Articles approved by the Scientific Committee and Editorial Board are eligible to be released after receiving at least two positive opinions from the Scientific Committee members of the Tr-ENT. Those committees have the authority to make all corrections and abbreviations but not to change the content of the article.
The authors have the all the scientific and legal responsibilities of the manuscripts. The authors must fully obey the ethics of research and publication.
All published material will become the sole property and will be copyrighted by the Journal. No part of the publication may be used without prior written permission of the publisher. Articles and illustrations become the property of the Journal after publication.
There is no fee for article submission, article processing or publication.
Open Access and Commons User Licenses
The Tr-ENT is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
Commons User Licenses
Creative Commons Attribution-NonCommercial (CC BY-NC) For non-commercial purposes, lets others distribute and copy the article, and to include in a collective work, as long as they credit the author(s) and provided they do not alter or modify the article.
Registration and login are required to submit items online and to check the status of current submissions. Users should visit journal’s web site (www.tr-ent.com, www.tr-ent.org) and create an account before submitting their manuscripts.
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
Tr-ENT publishes as English original research, short clinical report, surgical techniques, case report, invited reviews and letters to the editor ENT-related. The Editor-in-Chief may request from the authors additional data, information, or complementary material concerning the manuscripts and the authors must comply with such requests.
Manuscripts should be prepared in accordance with the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” regularly updated by the International Committee of Medical Journal Editors (ICMJE), available at http://www.tr-ent.com
Tr-ENT expects the authors to comply with the ethics of research and publication. In human research, a statement of the informed consent of those who participated in the study is needed in the section of the “Materials and Methods”.
All studies should be carried out in accordance with the World Medical Association Declaration of Helsinki (http://www.wma.net/en/30publications/10policies/b3/), covering the latest revision date. Patient confidentiality must be protected according to the universally accepted guidelines and rules. In case of procedures that will apply to volunteers or patients, it should be stated that the study objects have been informed and given their approval before the study started. In case the authors do not have a local ethics committee, the principles outlined in the “Declaration of Helsinki” should have been followed. Authors should declare that they have followed the internationally accepted latest guidelines, when asked legislation and other related regulations and should sent “Approval of the Ethics Committee”.
Manuscripts reporting the results of experimental studies on animals must include a statement that the study protocol was approved by the animal ethics committee of the institution and that the study was conducted in accordance with the internationally accepted guidelines, including the Universal Declaration of Animal Rights, European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, Principles of Laboratory Animal Science, and the Handbook for the Care and Utilization of Laboratory Animals. Authors are strongly requested to send a record of the approval of the ethics committee with the manuscript. Furthermore, manuscripts on human and animal studies should describe procedures indicating the steps taken to eliminate pain and suffering.
Policy of Screening for Plagiarism
The manuscripts are scanned by the Publisher’s Office using the iThenticate program for determination of plagiarism and non-ethical situations.
Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with similarity and without citation. If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s). The journal uses iThenticate plagiarism screening tool to screen all submissions and to verify the originality of content before publication.
When a drug, product, hardware, or software program is mentioned within the main text, product information, including the name of the product, the producer of the product, and city and the country of the company (including the state if in USA), should be provided in parentheses in the following format: Discovery St PET/CT scanner (General Electric Medical Systems, Milwaukee, Wisconsin, USA).
Submission and Peer Review
The official language of the Journal is English. All submissions and correspondence throughout the review process must be conducted in English.
A technical review is performed to confirm that all of the required documentation has been submitted and to conduct a preliminary evaluation of the manuscript and supplementary files to assess suitability for the Journal. The manuscript will be returned to the Author in the event of any deficiency.
The Editorial Office of Tr-ENT then assigns the manuscript a number and begins the peer preview process. This journal operates a blind review process. Contributions deemed suitable are then typically sent to a minimum of two independent expert reviewers in the field of study to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final.
The peer review process is double-blind, i.e., both authors and referees are kept anonymous. Pre-evaluation process of each submission is carried out by the Editorial Board. Manuscripts may be rejected without peer review by the editor in chief if they do not comply with the instructions to authors or if they are beyond the scope of the journal. Any manuscript that does not conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, as reported at http://www.icmje.org/icmje-recommendations.pdf, will also be rejected. Manuscripts are scanned for plagiarism or duplication. In case of an ethical issue on plagiarism or duplication, the Editorial Board will act in accordance with the Committee on Publication Ethics (COPE). The manuscripts which pass this stage are assigned to at least two double-blind peer-reviewers with a statistics reviewer. Reviewers are selected among independent experts who has published publications in the international literature on the submission subject and received considerable amount of citations. Research articles, systematic reviews, and meta-analyses are also reviewed by a biostatistician. By submitting a manuscript to the journal, authors accept that editor may implement changes on their manuscripts including misleading statements and mistypings, as long as the main idea of the manuscript is not interfered. Manuscripts submitted to The Turkish Journal of Ear Nose and Throat will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in their fields to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor-inChief is the final authority in the decision-making process for all submissions.
Correction and retraction of articles
Corrections may be made to a published article with the authorization of the editor of the journal. Editors will decide the magnitude of the corrections. Minor corrections are made directly to the original article. However, in cases of major corrections, the original article will remain unchanged, while the corrected version will also be published and linked to the corrected version. A statement indicating the reason for the major change to the article will also be published. When necessary, retraction of articles will be done according to the Committee on Publication Ethics (COPE) retraction guidelines. https://publicationethics.org/resources/guidelines
Copyright - Authors’ Approval - Conflict of Interest
The authors should disclose all issues concerning financial relationship, conflict of interest, and competing interest that may potentially influence the results of the research or scientific judgment. All financial contributions or sponsorship, financial relations, and areas of conflict of interest should be clearly explained in a separate letter to the editor at the time of submission, with full assurance that any related document will be submitted to the Journal when requested.
Manuscripts should be sent with the Copyright-Authors’ Approval-Conflict of Interest Letter signed by the author(s). A copy of this letter can be found at http://www.tr-ent.com. Manuscripts will not be accepted for evaluation until the receipt of this document by the Journal.
Any financial grants or other support received for the study from individuals or institutions must be disclosed to the Editorial Board and the International Committee of Medical Journal Editors (ICMJE) Potential Conﬂict of Interest Disclosure Form must be filled and submitted to disclose potential conﬂicts of interest. The manuscripts must be prepared in accordance with ICMJE Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals (updated in December 2014 - http://www.icmje.org/icmje-recommendations.pdf). Authors are required to prepare manuscripts in accordance with the CONSORT guidelines for randomized research studies, the STROBE guidelines for the observational original research studies, the STARD guidelines for the diagnostic accuracy studies, the PRISMA guidelines for systematic reviews and meta-analyses, the ARRIVE guidelines for the experimental animal studies, and the TREND guidelines for non-randomized public behaviors.
Submitting a Manuscript
Manuscripts should be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals regularly updated by the International Committee of Medical Journal Editors, available at http://www.tr-ent.com.
Submission and tracking of a manuscript can only be made online through the http://www.tr-ent.com web site at http://www.journalagent.com/tr-ent. Corresponding author should register to http://www.journalagent.com/tr-ent web site and login to start a submission process.
PREPERATION OF MANUSCRIPT
Material and methods
Material and methods
Conflict of interest:
Before the corresponding author submits the manuscript, all authors must obtain ORCİD ID number and provide it to the corresponding author.
The “Copyright Transfer Form” after being signed by all authors should be uploaded using the article accepting system of the Tr-ENT.
The title of article, short title, author name(s), names of institutions and the departments of the authors, full address, telephone numbers (landline and mobile) and e-mail address should be given. The title should be short and written in lower case. In addition, the running title should be written and it should not exceed 40 characters.
The microorganism’s Latin names of used for the first time in the text have to be written in full. If these names are used later, they should be abbreviated in accordance to international scientific rules. The original Latin names of microorganisms should be written in Italic style: for example, Staphylococcus aureus, S. aureus. The antibiotics’ names should be abbreviated in accordance with international standards and they should be used with generic names.
Symbols of the international units mentioned in the text should be according to “The Systeme International (SI).
Manuscripts should be written in one of the “past perfect, present perfect and past tenses” and in the passive mode.
A4 paper should be used and should have a 2.5 cm margin on each side. Times New Roman font, 12 pt, and 1.5 lines space should be used.
Tr-ENT expects the authors to comply with the ethics of research and publication. In human research, a statement of the informed consent of those who participated in the study is needed in the section of the “Materials and Methods”. In case animal studies, approval also is needed. Please, see at: Ethical issue.
In Original Articles; Research/Original manuscripts should consist of English abstract.
Introduction, Materials and Methods, Results, Discussion, Acknowledgements (if any), and References sections. These sections should be written in bold capital letters and aligned left.
Abstract: The abstract should be structured like the Objective, Methods, Results, and Conclusion. It should be between 200 and 250 words.
Keywords: The number of keywords should be between 3-6 and the terminology of the Medical Subjects Headings (Index Medicus Medical Subject Headings - MeSH) should be used. Please check at: https://www.nlm.nih.gov/mesh/MBrowser.html
Introduction: The aim of the study, and references given to similar studies should be presented briefly and should not exceed more than two pages.
Materials and Methods: The date of the study, institution that performed the study, and materials and methods should be clearly presented. Statistical methods should be clearly stated. All research manuscripts will send to professional statistician for their statistical evaluation by the Editor.
Results: The results should be stated clearly and only include the current research.
Conclusions: In this section, the study findings should be compared with the findings of other researchers. Authors should mention their comments in this section.
Acknowledgements: Acknowledgements should be placed at the end of the main text and before the references. In this section, the institutions/departments and person which supported the research should be stated. I) The study supported by a fund or scientific organization must be mentioned in the acknowledgements. II) The study presented in a conference/symposium must be mentioned with the type of presentation in the acknowledgements.
References: Authors are responsible for supply complete and correct references. References should be numbered according to the order used in the text.
Numbers should be given in brackets and placed at the end of the sentence. Examples are given below on the use of references. Reference end note style Vancouver
Periodicals: Author(s) Last Name initial(s) name of author(s) (if there are six or fewer authors, all authors should be written; if the number of authors are seven or more, only the first six of the authors should be written and the rest as “et al”). The title of the article, the abbreviated name of the journal according to the Index Medicus, Year; Volume (Issue): The first and last page numbers.
Robson A, Greene J, Ansari N, Kim B. Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathologic study of 69 cases. The American Journal of Surgical Pathology. 2001;25:710-20.Books: Surname of the author(s) initial name(s) of author(s). The name of the book. The edition number. Place of publication: Publisher, Publication year.
Book chapters: The author (s) surname of the chapter initial (s) letter of the name. Section title. In: Surname of editor (s) initial (s) letter of first name (s) ed / eds. The name of the book. Edition number. Place of publication: Publisher, year of publication: The first and last page numbers of the chapter.
Web address: If a “web” address is used as the reference address, the web address date should be given in brackets with the address. The DOI (Digital Object Identifier) number must be provided, when a web access article used in the text as a reference.
Example: AB Author, CD Author. Title of document. Retrieved from http://Web address (Accession date: aa/bb/2016).
Thesis: Maden KL. Experimental investigation of the â¦â¦â¦â¦â¦.. Master Thesis, Health Science Institute of Ankara University, Ankara, 2005.
Figure and Tables:
Each table or figure should be printed on a separate sheet, the top and bottom lines and if necessary column lines must be included.
Tables should be numbered like “Table 1.” and the table title should be written above the top line of the table. Explanatory information should be given in footnotes, not in the title and appropriate icons (*,+,++, etc.) should be used.
Photos should be in “JPEG” format. In case the quality of the photos is not good for publication, the originals can be requested.
Submission Preparation Checklist
As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
All authors must obtain ORCİD ID number and provide it to the corresponding author.
Abstract, 200 - 250 words or shorter
Manuscript without abstract, structured correctly
References at the end of the manuscript, listed in order of citation
All figures sent separately and not embedded in the manuscript
Figure legends included at the end of the manuscript
All figures and tables are cited in the manuscript
A letter of copyright transfer, signed by all authors
Endnote reference style: Vancouver
When submitting a revised version of a paper, the author must submit a detailed Response to the reviewers that states point by point how each issue raised by the reviewers has been covered and where it can be found (each reviewers comment, followed by the authors reply and line numbers where the changes have been made) as well as an annotated copy of the main document. Revised manuscripts must be submitted within 30 days from the date of the decision letter. If the revised version of the manuscript is not submitted within the allocated time, the revision option may be canceled. If the submitting author(s) believe that additional time is required, they should request this extension before the initial 30-day period is over.
Accepted manuscripts are copy-edited for grammar, punctuation, and format. Once the publication process of a manuscript is completed, it is published online on the journals webpage as an ahead-of-print publication before it is included in its scheduled issue. A PDF proof of the accepted manuscript is sent to the corresponding author and their publication approval is requested within two days of their receipt of the proof. The latest status of the submitted manuscripts and other information about the journal can be accessed at http://tr-ent.com.
The editorial and publication processes of the journal are conducted in accordance with the guidelines of the International Council of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE), the European Association of Science Editors (EASE), and National Information Standards Organization (NISO). The journal conforms to the Principles of Transparency and Best Practice in Scholarly Publishing (doaj.org/bestpractice). An ORCID ID is required for all authors during the submission of the manuscript. The ID is available at http://orcid.org with free of charge.